Gregor Hoermann
Overview
Explore the profile of Gregor Hoermann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
154
Citations
2748
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Suske T, Sorger H, Manhart G, Ruge F, Prutsch N, Zimmerman M, et al.
J Clin Invest
. 2024 Apr;
134(8).
PMID: 38618957
T cell acute lymphoblastic leukemia (T-ALL) is an aggressive immature T cell cancer. Mutations in IL7R have been analyzed genetically, but downstream effector functions such as STAT5A and STAT5B hyperactivation...
12.
Klein K, Kollmann S, Hiesinger A, List J, Kendler J, Klampfl T, et al.
Blood
. 2024 Mar;
143(24):2474-2489.
PMID: 38498036
Patients with T- and natural killer (NK)-cell neoplasms frequently have somatic STAT5B gain-of-function mutations. The most frequent STAT5B mutation is STAT5BN642H, which is known to drive murine T-cell leukemia, although...
13.
Piehler A, Truger M, Kozik J, Weissmann S, Schwonzen M, Meggendorfer M, et al.
Haematologica
. 2024 Mar;
109(8):2745-2748.
PMID: 38497167
No abstract available.
14.
Greiner G, Witzeneder N, Klein K, Tangermann S, Kodajova P, Jaeger E, et al.
Blood
. 2023 Dec;
143(11):1006-1017.
PMID: 38142424
Systemic mastocytosis (SM) is defined by the expansion and accumulation of neoplastic mast cells (MCs) in the bone marrow (BM) and extracutaneous organs. Most patients harbor a somatic KIT D816V...
15.
Baumgartner F, Baer C, Bamopoulos S, Ayoub E, Truger M, Meggendorfer M, et al.
Blood
. 2023 Dec;
143(12):1139-1156.
PMID: 38064663
The World Health Organization (WHO) classification of hematolymphoid tumors and the International Consensus Classification (ICC) of 2022 introduced major changes to the definition of chronic myelomonocytic leukemia (CMML). To assess...
16.
Frank D, Patnana P, Vorwerk J, Mao L, Gopal L, Jung N, et al.
Blood
. 2023 Sep;
142(25):2175-2191.
PMID: 37756525
Growth factor independence 1 (GFI1) is a DNA-binding transcription factor and a key regulator of hematopoiesis. GFI1-36N is a germ line variant, causing a change of serine (S) to asparagine...
17.
Bauer K, Machherndl-Spandl S, Kazianka L, Sadovnik I, Gultekin S, Suessner S, et al.
Leukemia
. 2023 Sep;
37(11):2250-2260.
PMID: 37673973
Myelodysplastic syndromes (MDS) are myeloid neoplasms presenting with dysplasia in the bone marrow (BM) and peripheral cytopenia. In most patients anemia develops. We screened for genes that are expressed abnormally...
18.
Huber S, Baer C, Hutter S, Dicker F, Fuhrmann I, Meggendorfer M, et al.
Leukemia
. 2023 Aug;
37(10):2138-2141.
PMID: 37573403
No abstract available.
19.
Pencik J, Philippe C, Schlederer M, Atas E, Pecoraro M, Grund-Groschke S, et al.
Mol Cancer
. 2023 Aug;
22(1):133.
PMID: 37573301
Prostate cancer (PCa) is a common and fatal type of cancer in men. Metastatic PCa (mPCa) is a major factor contributing to its lethality, although the mechanisms remain poorly understood....
20.
Valent P, Hoermann G, Bonadonna P, Hartmann K, Sperr W, Broesby-Olsen S, et al.
J Allergy Clin Immunol Pract
. 2023 Aug;
11(10):3010-3020.
PMID: 37572755
Physiological levels of basal serum tryptase vary among healthy individuals, depending on the numbers of mast cells, basal secretion rate, copy numbers of the TPSAB1 gene encoding alpha tryptase, and...